UnknownNot Applicable

Application of Three-Dimensionally Printed Navigational Template in Lung Biopsy

China150 participantsStarted 2020-11-25

Plain-language summary

This is a prospective, randomized, controlled study to evaluate the diagnostic yield and safety of three-dimensionally printed navigational template in percutaneous transthoracic lung biopsy.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Ⅰ. Inclusion Criteria: A. CT confirmed peripheral lung lesion; B. Nodule size larger than or equal to 30 mm; C. Scheduled for percutaneous transthoracic fine-needle aspiration; D. Percutaneous transthoracic lung biopsy was conducted at supine or partially lateral decubitus; E. Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2; F. Written informed consent provided. Ⅱ. Exclusion Criteria: A. Biopsy needle insertion route impeded by skeletal structures; B. Lesion within 3 cm above diaphragmatic dome; C. Insertion route longer than the biopsy needle; D. Lung biopsy needed to be conducted at vertically lateral decubitus; E. Any contraindication of percutaneous transthoracic lung biopsy; F. Women who are pregnant or in the period of breastfeeding.

What they're measuring

Diagnostic yield of percutaneous transthoracic fine-needle aspiration

Timeframe: Three to four working days post-biopsy were needed to establish the diagnosis of the cytological specimens acquired by fine-needle aspiration.

Trial details

NCT IDNCT04775901

SponsorShanghai Pulmonary Hospital, Shanghai, China

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-31

Contact for this trial

Haoran E, MD

+86-021-19916946180 ehaoran@126.com

View on ClinicalTrials.gov More Lung Neoplasms trials